According to the research report, the global point-of-caretesting market size is expected to touch USD 103.2 Billion by 2030, from USD 40.6 Billion in 2021, growing with a significant CAGR of 10.92% from 2022 to 2030.
The point-of-care testing market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global point-of-care testing market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global point-of-care testing market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global point-of-care testing market during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample Link https://www.precedenceresearch.com/sample/2270
| Report Coverage | Details |
| Market Size in 2022 | USD 45.03 Billion |
| Market Size by 2030 | USD 103.2 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 10.92% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product Type, Platform, Mode of Purchase, Testing Type, End-User, and Geography |
This study covers a detailed segmentation
of the global point-of-care testing market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global point-of-care testing market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players are Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc
Market Segmentation
- Covid -19 testing kits
- Glucose monitoring products
- Meters
- Strips
- Lancets and Lancing devices
- Cardiometabolic Monitoring Products
- Cardiac maker testing products
- Blood Gas / Electrolyte testing products
- HbA1c testing products
- Infectious disease testing products
- Influenza testing products
- HIV testing products
- Hepatitis testing products
- Sexually Transmitted Diseases testing products
- Healthcare - associated Infection testing products
- Respiratory infection testing products
- Tropical disease testing products
- others
- Coagulation monitoring products
- PT / INR testing
- ACT / APTT
- Pregnancy and fertility testing products
- Pregnancy testing products
- Fertility testing products
- Cancer marker testing products
- Urinanalysis testing products
- Cholestrol testing products
- Hematology testing products
- Drugs-of-abuse testing products
- Fecal Occult testing products
- Others
By Platform
- Lateral Flow Assays
- Dipsticks
- Microfluids
- Molecular Diagnostics
- Immunoassays
By Mode of Purchase
- OTC products
- Prescribed based products
By Testing Type
- Immunoassays
- Cell-Based Assays
- Nucleic Acid Amplification Testing
- Clinical Chemistry Assays
- Hematology
By End-User
- Clinical laboratories
- Ambulatory care facilities and physician offices
- Pharmacies, retail clinics & E-comm platforms
- Hospitals, Critical care centres, Urgent care centres
- Home care & self-testing
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global point-of-care testing market report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global point-of-care testing market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market
5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type
8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2022-2030
8.1.1. Covid -19 testing kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Glucose monitoring products
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Cardiometabolic Monitoring Products
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Infectious disease testing products
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Coagulation monitoring products
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Pregnancy and fertility testing products
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Pregnancy testing products
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Fertility testing products
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Cancer marker testing products
8.1.9.1. Market Revenue and Forecast (2017-2030)
8.1.10. Urinanalysis testing products
8.1.10.1. Market Revenue and Forecast (2017-2030)
8.1.11. Cholestrol testing products
8.1.11.1. Market Revenue and Forecast (2017-2030)
8.1.12. Hematology testing products
8.1.12.1. Market Revenue and Forecast (2017-2030)
8.1.13. Drugs-of-abuse testing products
8.1.13.1. Market Revenue and Forecast (2017-2030)
8.1.14. Fecal Occult testing products
8.1.14.1. Market Revenue and Forecast (2017-2030)
8.1.15. Others
8.1.15.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform
9.1. Point-of-Care Testing (POCT) Market, by Platform, 2022-2030
9.1.1. Lateral Flow Assays
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dipsticks
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Microfluids
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Molecular Diagnostics
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Immunoassays
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase
10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2022-2030
10.1.1. OTC products
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Prescribed based products
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type
11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2022-2030
11.1.1. Immunoassays
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cell-Based Assays
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Nucleic Acid Amplification Testing
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Clinical Chemistry Assays
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Hematology
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User
12.1. Point-of-Care Testing (POCT) Market, by End-User, 2022-2030
12.1.1. Clinical laboratories
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Ambulatory care facilities and physician offices
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Pharmacies, retail clinics & E-comm platforms
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Hospitals, Critical care centres, Urgent care centres
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Home care & self-testing
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.5. Market Revenue and Forecast, by End-User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.5. Market Revenue and Forecast, by End-User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.7. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.8. Market Revenue and Forecast, by End-User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.10. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.11. Market Revenue and Forecast, by End-User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.13. Market Revenue and Forecast, by End-User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.15. Market Revenue and Forecast, by End-User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.5. Market Revenue and Forecast, by End-User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.7. Market Revenue and Forecast, by End-User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.9. Market Revenue and Forecast, by End-User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.7. Market Revenue and Forecast, by End-User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.9. Market Revenue and Forecast, by End-User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.5. Market Revenue and Forecast, by End-User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.7. Market Revenue and Forecast, by End-User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 14. Company Profiles
14.1. Sinocare Inc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Hoffmann La Roche Ltd
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Siemens AG
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Abott Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. bioMrieux SA
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Becton Dickinson and Company
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher Coraporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nova Biomedical
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9.Sysmex corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Johnson and Johnson
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments